(Q36715746)

15 August 2017

1 reference

title

Recent progress on the topical therapy of onychomycosis (English)

1 reference

15 August 2017

Michael R K Alley

1

1 reference

15 August 2017

Stephen J Baker

series ordinal

2

1 reference

15 August 2017

Karl R Beutner

series ordinal

3

1 reference

15 August 2017

Jacob Plattner

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

published in

1 reference

15 August 2017

volume

16

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

157-167

1 reference

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

New developments in chemotherapy for non-invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Onychomycosis in clinical practice: factors contributing to recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Treatment failures and relapses in onychomycosis: a stubborn clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Drug delivery to the nail following topical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Long-term outcomes in the treatment of toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Pharmacotherapy of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Griseofulvin inhibits Fungal Mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

21 January 2018

Ciclopirox: an overview.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

The use of topical therapies to treat onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Onychomycosis: current treatment and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

The antifungal activity of mupirocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

The 2 Å crystal structure of leucyl-tRNA synthetase and its complex with a leucyl-adenylate analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Enzyme structure with two catalytic sites for double-sieve selection of substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Insights into editing from an ile-tRNA synthetase structure with tRNAile and mupirocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.2.157

10.1517/13543784.16.2.157

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference